Assessment and treatment of depression in medically ill children

Eyal Shemesh1, Abraham Bartell, Jeffrey H Newcorn

  • 1Division of Child and Adolescent Psychiatry, Department of Psychiatry, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029, USA. eyal.shymesh@mssm.edu

Insights

Depression in medically ill children worsens their health and treatment adherence. Addressing this high-risk group requires careful study of effective treatment options for better outcomes.

Area of Science:

  • Pediatric Medicine
  • Child Psychiatry
  • Psychosomatic Medicine

Background:

  • Depression in medically ill children leads to disability, morbidity, and exacerbation of medical conditions.
  • These children often exhibit nonadherence to prescribed medical treatments.
  • Medically ill children with depression represent a unique, high-risk population with potentially severe health consequences.

Purpose of the Study:

  • To review the diagnostic and treatment challenges of depression in medically ill children.
  • To highlight the need for further research into effective interventions for this population.

Main Methods:

  • This manuscript presents a review of existing literature and clinical considerations.
  • It focuses on methodologic and practical difficulties in diagnosing and treating depression in this specific patient group.

Main Results:

  • Depression diagnosis and treatment in medically ill children present significant challenges.
  • Effective management of depression can potentially improve both medical and psychiatric outcomes.

Conclusions:

  • Medically ill children with depression require specialized attention due to heightened risks.
  • Further research is crucial to establish optimal treatment strategies for improved patient outcomes.

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...